Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 5
2005 3
2006 1
2008 2
2009 1
2010 4
2011 6
2013 4
2014 9
2015 5
2016 6
2017 9
2018 6
2019 12
2020 8
2021 9
2022 9
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, Wellington E, Khawam J, Munro K, Cole M, Tranquillini C, Taylor-Kerr A, Hettiarachchi N, Calbraith D, Sajedi N, Milligan I, Themistocleous Y, Corrigan D, Cromey L, Price L, Stewart S, de Lacy E, Norman C, Linley E, Otter AD, Semper A, Hewson J, D'Arcangelo S, Chand M, Brown CS, Brooks T, Islam J, Charlett A, Hopkins S; SIREN Study Group. Hall V, et al. Among authors: sajedi n. N Engl J Med. 2022 Mar 31;386(13):1207-1220. doi: 10.1056/NEJMoa2118691. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172051 Free PMC article.
Predictors of treatment switching in the Big Multiple Sclerosis Data Network.
Spelman T, Magyari M, Butzkueven H, Van Der Walt A, Vukusic S, Trojano M, Iaffaldano P, Horáková D, Drahota J, Pellegrini F, Hyde R, Duquette P, Lechner-Scott J, Sajedi SA, Lalive P, Shaygannejad V, Ozakbas S, Eichau S, Alroughani R, Terzi M, Girard M, Kalincik T, Grand'Maison F, Skibina O, Khoury SJ, Yamout B, Sa MJ, Gerlach O, Blanco Y, Karabudak R, Oreja-Guevara C, Altintas A, Hughes S, McCombe P, Ampapa R, de Gans K, McGuigan C, Soysal A, Prevost J, John N, Inshasi J, Stawiarz L, Manouchehrinia A, Forsberg L, Sellebjerg F, Glaser A, Pontieri L, Joensen H, Rasmussen PV, Sejbaek T, Poulsen MB, Christensen JR, Kant M, Stilund M, Mathiesen H, Hillert J; Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP. Spelman T, et al. Among authors: sajedi sa. Front Neurol. 2023 Dec 22;14:1274194. doi: 10.3389/fneur.2023.1274194. eCollection 2023. Front Neurol. 2023. PMID: 38187157 Free PMC article.
Anti-amyloidogenic effect of artemin on α-synuclein.
Marvastizadeh N, Dabirmanesh B, Sajedi RH, Khajeh K. Marvastizadeh N, et al. Among authors: sajedi rh. Biol Chem. 2020 Sep 25;401(10):1143-1151. doi: 10.1515/hsz-2019-0446. Biol Chem. 2020. PMID: 32673279
Choroid plexus tumours.
Wolff JE, Sajedi M, Brant R, Coppes MJ, Egeler RM. Wolff JE, et al. Among authors: sajedi m. Br J Cancer. 2002 Nov 4;87(10):1086-91. doi: 10.1038/sj.bjc.6600609. Br J Cancer. 2002. PMID: 12402146 Free PMC article.
Histology was the most important prognostic factor, as one, five, and 10-year projected survival rates were 90, 81, and 77% in choroid plexus-papilloma (n=353) compared to only 71, 41, and 35% in choroid plexus-carcinoma respectively (P<0.0005). Surgery was prognostical …
Histology was the most important prognostic factor, as one, five, and 10-year projected survival rates were 90, 81, and 77% in choroid plexu …
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Daruwalla C, Shaygannejad V, Ozakbas S, Havrdova EK, Horakova D, Alroughani R, Boz C, Patti F, Onofrj M, Lugaresi A, Eichau S, Girard M, Prat A, Duquette P, Yamout B, Khoury SJ, Sajedi SA, Turkoglu R, Altintas A, Skibina O, Buzzard K, Grammond P, Karabudak R, van der Walt A, Butzkueven H, Maimone D, Lechner-Scott J, Soysal A, John N, Prevost J, Spitaleri D, Ramo-Tello C, Gerlach O, Iuliano G, Foschi M, Ampapa R, van Pesch V, Barnett M, Shalaby N, D'hooghe M, Kuhle J, Sa MJ, Fabis-Pedrini M, Kermode A, Mrabet S, Gouider R, Hodgkinson S, Laureys G, Van Hijfte L, Macdonell R, Oreja-Guevara C, Cristiano E, McCombe P, Sanchez-Menoyo JL, Singhal B, Blanco Y, Hughes S, Garber J, Solaro C, McGuigan C, Taylor B, de Gans K, Habek M, Al-Asmi A, Mihaela S, Castillo Triviño T, Al-Harbi T, Rojas JI, Gray O, Khurana D, Van Wijmeersch B, Grigoriadis N, Inshasi J, Oh J, Aguera-Morales E, Fragoso Y, Moore F, Shaw C, Baghbanian SM, Shuey N, Willekens B, Hardy TA, Decoo D, Sempere AP, Field D, Wynford-Thomas R, Cunniffe NG, Roos I, Malpas CB, Coles AJ, Kalincik T, Brown JWL. Daruwalla C, et al. Among authors: sajedi sa. Mult Scler. 2023 Jun;29(7):875-883. doi: 10.1177/13524585231151951. Epub 2023 Feb 27. Mult Scler. 2023. PMID: 36851894 Free PMC article.
Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review.
Fattahi AS, Amini G, Sajedi F, Mehrad-Majd H. Fattahi AS, et al. Among authors: sajedi f. Breast J. 2023 Sep 26;2023:9947797. doi: 10.1155/2023/9947797. eCollection 2023. Breast J. 2023. PMID: 37794976 Free PMC article. Review.
Only antibiotic and expectant treatments had significant differences in recurrence rates compared to other treatments (p value = 0.023). In conclusion, factors such as Caucasian race, pregnancy and breastfeeding history, and use of contraceptive hormone are commonly associ …
Only antibiotic and expectant treatments had significant differences in recurrence rates compared to other treatments (p value = 0.02 …
Coenzyme Q10 as a potential add-on treatment for patients suffering from painful diabetic neuropathy: results of a placebo-controlled randomized trial.
Amini P, Sajedi F, Mirjalili M, Mohammadi Y, Mehrpooya M. Amini P, et al. Among authors: sajedi f. Eur J Clin Pharmacol. 2022 Dec;78(12):1899-1910. doi: 10.1007/s00228-022-03407-x. Epub 2022 Oct 22. Eur J Clin Pharmacol. 2022. PMID: 36273066 Clinical Trial.
By the end of week 2, the decrease in the mean pain NRS score was similar in both groups, but at the end of weeks four and eight, the decrease in the mean pain NRS score was significantly greater in patients taking CoQ10 + pregabalin than in those taking placebo + pregabalin ( …
By the end of week 2, the decrease in the mean pain NRS score was similar in both groups, but at the end of weeks four and eight, the decrea …
The Impact of Excessive Body Weight and Foot Pronation on Running Kinetics: A Cross-Sectional Study.
Jafarnezhadgero AA, Jahangirpour A, Parsa H, Sajedi H, Granacher U, Souza Oliveira A. Jafarnezhadgero AA, et al. Among authors: sajedi h. Sports Med Open. 2023 Dec 6;9(1):116. doi: 10.1186/s40798-023-00663-8. Sports Med Open. 2023. PMID: 38055073 Free PMC article.
RESULTS: The results indicated significantly lower vertical impact peak forces (p = 0.001, effect size = 0.12), shorter time to reach the vertical impact peak (p = 0.006, effect size = 0.08) and reduced vertical loading rate (p = 0.0007, effect size = 0.13) i …
RESULTS: The results indicated significantly lower vertical impact peak forces (p = 0.001, effect size = 0.12), shorter time to reach …
Recreational runners who recovered from COVID-19 show different running kinetics and muscle activities compared with healthy controls.
Jafarnezhadgero AA, Hamlabadi MP, Sajedi H, Granacher U. Jafarnezhadgero AA, et al. Among authors: sajedi h. Gait Posture. 2022 Jan;91:260-265. doi: 10.1016/j.gaitpost.2021.11.002. Epub 2021 Nov 6. Gait Posture. 2022. PMID: 34775229 Free PMC article.
Moreover, higher peak lateral GRFs were found during heel contact (p = 0.001; d=1.536) in the COVID group. COVID-19 individuals showed a shorter time-to-reach the peak vertical (p = 0.001; d=3.779) and posterior GRFs (p = 0.005; d=1.099) during heel contact. …
Moreover, higher peak lateral GRFs were found during heel contact (p = 0.001; d=1.536) in the COVID group. COVID-19 individuals showe …
Analgesic effect of curcumin topical formulation in knee osteoarthritis patients: a clinical trial.
Azadbakht Z, Sajedi F, Mahboobian MM, Mohammadi M, Ataei S. Azadbakht Z, et al. Among authors: sajedi f. J Basic Clin Physiol Pharmacol. 2022 Feb 1;34(1):41-48. doi: 10.1515/jbcpp-2021-0255. eCollection 2023 Jan 1. J Basic Clin Physiol Pharmacol. 2022. PMID: 35107231 Clinical Trial.
Based on our results, VAS and WOMAC index were altered after treatment significantly (p<0.0001). CONCLUSIONS: Two-week use of curcumin ointment could ameliorate the pain, stiffness and function disability in patients with OA....
Based on our results, VAS and WOMAC index were altered after treatment significantly (p<0.0001). CONCLUSIONS: Two-week use of curc …
107 results